Synapticure Analysis: $6M Raised
What is Synapticure?
Synapticure offers telehealth services for neurodegenerative diseases, providing personalized care and support for patients with ALS, Parkinson's, Alzheimer's, and other dementias.
Employees
35
Founded
2019
Revenue
$5-21M
Product Features & Capabilities
- Cognitive Care, Alzheimer's Disease support, Frontotemporal Dementia services, Lewy Body Dementia services, Movement Care for Parkinson's Disease, Huntington's Disease support, Neuromuscular Care for ALS and Primary Lateral Sclerosis, Mental Health Care, Care Coordination, Insurance Management & Pri
Pricing
- First consultation with a Care Coordinator is free.
- No subscription fee; services billed to health plans.
- Average cost for in-network visits is $0-40.
How much Synapticure raised
Seed - $6 million
February 1, 2022Lead Investor: Led by GV (formerly Google Ventures)
Who are the founders of Synapticure
PW
Peter Wallach
Founder / Founding CEO
BW
Brian Wallach
Founder
MD
Martina de Majo
Director of Research and Development
Market Focus
Synapticure primarily focuses on the telehealth industry, specifically providing services for patients with neurodegenerative diseases such as ALS, Parkinson's, Alzheimer's, and other dementias.
Investors
- B Capital
- CommonSpirit Health
- CVS Health Ventures
- RA Capital Management
- Nexus NeuroTech Ventures
Business Model
Revenue from insurance billing for telehealth services and partnerships with healthcare providers.
Competitors Overview
Synapticure operates in the telehealth market for neurodegenerative diseases, facing competition from several notable companies:
- Rippl Care: Focuses on providing mental health services for seniors, particularly those with neurodegenerative conditions. Their advantage lies in a specialized ap
See something that needs updating? Suggest edits to this profile.